Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Board
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Treatment Efficacy for Pediatric Acute Myeloid Leukemias: Results of a Single-Center Trial

    E.V. Inyushkina, Sergei Olegovich Gunyakov, A.V. Bogucharskii, V.O. Stepanova
    142-151
    01.04.2026
  • Clinical Features and Treatment Outcomes of HIV-Associated Diffuse Large B-Cell Lymphoma

    Anastasia Borisovna Galitsyna, N.A. Falaleeva, O.V. Levkovskiy, V.A. Shuvaev, A.Yu. Terekhova, M.G. Syadrin, E.A. Norot, A.M. Chelmakov, S.A. Ivanov, A.D. Kaprin
    49-58
    01.01.2026
  • The Prognostic Value of Positron Emission Tomography Findings in the Treatment of Primary Mediastinal (Thymic) Large B-Cell Lymphoma

    A.S. Subbotin, Arman Vachakanovich Arakelyan, G.S. Tumyan, V.V. Solomyanyi, B.M. Khakulova, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, U.G. Koshkina, O.P. Trofimova, M.A. Senchenko, V.Yu. Kirsanov
    326-339
    01.10.2025
  • Determination of the Minimal Residual Disease Threshold in Acute Myeloid Leukemia Treated with ‘ОМЛ-17’ and ‘mОМЛ-17’ Regimens

    Irina Vladimirovna Galtseva, E.N. Parovichnikova, K.A. Nikiforova, Yu.O. Davydova, N.M. Kapranov, I.A. Lukianova, A.A. Ievleva, Yu.A. Chabaeva, Z.T. Fidarova, L. A. Kuzmina, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov
    340-346
    01.10.2025
  • Analysis of Plasma Circulating Cell-Free DNA in Acute Myeloid Leukemia Patients

    Elena Nikolaevna Voropaeva, M.V. Burundukova, I.A. Kuznetsova, P.S. Orlov, A.M. Nesterets, S.V. Minnikh, V.N. Maximov, T.I. Pospelova
    347-354
    01.10.2025
  • Pathogenesis of Respiratory Distress in Acute Leukemia with Hyperleukocytosis

    Regina Ramilevna Tukhvatullina, N.V. Matinyan, T.T. Valiev, O.A. Ignatenko, N.V. Kokosadze, S.R. Varfolomeeva
    372-379
    01.10.2025
  • The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

    Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov
    233-241
    01.07.2025
  • Efficacy and Safety of Ruxolitinib in Primary Myelofibrosis Patients with Abdominal Thrombotic Complications: A Case Series

    Yu.P. Martinova, E.V. Borovitskaya, S.S. Lebedeva, E.R. Efimova, O.E. Filippova, K.M. Chernysh, A.P. Smaglyuk, L.I. Napso, N.V. Novospasskaya, L.V. Kucheryavykh, Tamara Vangelevna Chitanava
    250-256
    01.07.2025
  • Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review

    Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin
    153-162
    01.04.2025
  • Theoretical and Practical Aspects of Studying the Fractions of BAALC-Expressing Hematopoietic Stem Cells in Acute Myeloid Leukemia Patients with FLT3 Mutations

    Nikolai Nikolaevich Mamaev, M.M. Kanunnikov, A.I. Shakirova, I.M. Barkhatov, A.M. Sadykov, B.I. Ayubova, T.L. Gindina, J.J. Vlasova, S.N. Bondarenko
    73-85
    01.01.2025
  • Development and Testing of Electronic Patient-Reported Outcome System “Health – Electronic Self-Assessment” (HESA) for Monitoring the Health Status of Patients with Hematologic Malignancies Based on Their Quality-of-Life Data

    Tatyana Pavlovna Nikitina, V.Ya. Melnichenko, D.A. Fedorenko, V.O. Sarzhevskiy, A.E. Bannikova, V.S. Bogatyrev, A.A. Mamedova, N.E. Mochkin, A.K. Panchenko, A.A. Rukavisyn, A.A. Samoylova, N.S. Shorokhov, N.M. Porfireva, T.I. Ionova
    390-403
    01.10.2024
  • Cardiovascular Toxicity of CAR-T Cell Therapy: A Literature Review

    Shakhabutdin Murtuzalievich Murtuzaliev, E.Yu. Salakheeva, S.A. Kardovskaya, Yu.Yu. Kirichenko, E.A. Siderko, Yu.N. Belenkov, I.S. Ilgisonis
    404-414
    01.10.2024
  • Diagnostic Potential of Regulatory Non-Coding Protein RNAs in Chronic Lymphocytic Leukemia

    Igor Alekseevich Olkhovskii
    154-165
    01.04.2024
  • Xenotransplantation of Human Hematopoietic Stem Cells into NBSGW Mice: A Basic Model for Preclinical Development of Gene Therapy Approaches

    Alena Igorevna Shakirova, I.N. Gaponenko, Ya.V. Komarova, O.S. Epifanovskaya, D.A. Senichkina, V.S. Sergeev, A.R. Muslimov, A.V. Onopchenko, E.V. Shchelina, S.A. Osipova, O.G. Bredneva, M.L. Vasyutina, Ya.G. Toropova, K.V. Lepik, M.O. Popova, I.S. Moiseev, A.D. Kulagin
    82-93
    01.04.2024
  • BAALC-Expressing Leukemia Hematopoietic Stem Cells and Their Place in the Study of CBF-Positive Acute Myeloid Leukemias in Children and Adults

    M.M. Kanunnikov, Nikolai Nikolaevich Mamaev, T.L. Gindina, A.I. Shakirova, A.M. Sadykov, S.V. Razumova, S.N. Bondarenko, L.S. Zubarovskaya
    387-398
    28.09.2023
  • Long-Term Outcomes of Immunosuppressive Therapy for Aplastic Anemia: A Single-Center Experience

    Elena Romanovna Shilova, N.A. Romanenko, D.A. Chebykina, T.V. Glazanova, M.N. Zenina, I.E. Pavlova, S.S. Bessmeltsev
    321-330
    09.06.2023
  • Quality of Life Changes in Patients with Chronic Immune Thrombocytopenia in the Process of Romiplostim Therapy, its Efficacy and Safety in the Real-World Setting: Results of a Multi-Center Observational Study

    T.I. Ionova, O.Yu. Vinogradova, T.V. Shelekhova, D.G. Sherstnev, A.V. Proidakov, E.V. Lyyurova, M.M. Pankrashkina, L.A. Mukha, E.E. Markova, N.V. Novitskaya, T.I. Pospelova, T.N. Babaeva, N.B. Bulieva, G.B. Kuchma, E.A. Andreevskaya, E.E. Zinina, M.V. Frolova, K.B. Trizna, I.L. Shestopalova, T.V. Shneider, S.A. Volkova, S.G. Zakharov, I.I. Mulina, I.E. Solov’eva, A.A. Myasnikov, A.A. Kuchin, L.B. Khvorostenko, N.M. Porfirieva, Tatyana Pavlovna Nikitina, V.V. Ptushkin, S.V. Gritsaev
    154-165
    03.03.2023
  • Approaches to the Treatment of Patients with Myelofibrosis and Polycythemia Vera with Constitutional Symptoms in Real-World Clinical Practice in the Russian Federation: Intermediate Results of a Multi-Center Observational Prospective Clinical Study

    Anait Levonovna Melikyan, I.N. Subortseva, S.M. Kulikov, Yu.A. Chabaeva, E.A. Gilyazitdinova, K.P. Novoselov, E.A. Knyazeva, A.S. Egorova, I.S. Stepochkin, E.V. Koroleva, T.M. Sycheva, V.P. Belgesova, A.Yu. Putintseva, O.M. Senderova, I.V. Vasil’eva, E.Yu. Komartseva, A.A. Kaplina, V.I. Bakhtina, M.A. Mikhalev, Yu.B. Chernykh, E.N. Parovichnikova
    146-153
    03.03.2023
  • Monitoring of Red Cell Donor Chimerism in Oncohematological Patients After Allogeneic Hematopoietic Stem Cell Transplantation

    Mariya Viktorovna Smolnikova, E.V. Butina, A.V. Iovdii, E.A. Poponina, N.A. Zorina
    96-100
    01.01.2023
  • Multiple Myeloma: Nuances of Minimal Residual Disease Diagnosis and Monitoring with the Use of Multicolor Flow Cytometry

    I.V. Galtseva, Kseniya Aleksandrovna Nikiforova, Yu.O. Davydova, N.M. Kapranov, M.V. Solov’ev, E.N. Parovichnikova, L.P. Mendeleeva
    365-376
    01.10.2022
  • The Importance of Complementary Immunological Markers in the Diagnosis of Minimal Residual Disease in Multiple Myeloma

    E.E. Tolstykh, O.S. Chuvadar, A.A. Semenova, N.A. Kupryshina, O.P. Kolbatskaya, Yu.I. Klyuchagina, O.A. Kolomeitsev, G.S. Tumyan, Nikolai Nikolaevich Tupitsyn
    388-395
    01.10.2022
  • Herpes Virus Reactivation in Lymphoma Patients During and After Autologous Hematopoietic Stem Cell Transplantation

    Yana Konstantinovna Mangasarova, Yu.O. Davydova, D.S. Tikhomirov, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, F.E. Babaeva, A.E. Misyurina, M.O. Bagova, E.A. Fastova, A.U. Magomedova, I.V. Galtseva, T.A. Tupoleva, S.K. Kravchenko
    289-297
    01.07.2022
  • ROR-1 Expression in the Diagnosis and Monitoring of Minimal Residual Disease in Chronic Lymphocytic Leukemia

    Evgenii Vladimirovich Pochtar, S.A. Lugovskaya, E.V. Naumova, E.A. Dmitrieva, V.V. Dolgov
    148-155
    01.04.2022
  • Current State of Diagnosis and Treatment of Acute Myeloid Leukemias in Adult Patients in the Republic of Kazakhstan

    A.A. Klodzinskii, I.A. Pivovarova, L.G. Turgunova, Aimzhan Zharkynovna Anafina, A.V. Zinchenko
    69-75
    01.01.2022
  • Russian Prospective Non-Randomized Clinical Study on Dose Reduction of Tyrosine Kinase Inhibitors with Subsequent Complete Therapy Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response (READIT-2020): Background, Aim, Mai

    A.G. Turkina, Margarita Anatolevna Gurianova, E.Yu. Chelysheva, O.A. Shukhov
    54-61
    01.01.2022
  • Technical Aspects of Minimal Residual Disease Detection by Multicolor Flow Cytometry in Acute Myeloid Leukemia Patients

    I.V. Galtseva, Yuliya Olegovna Davydova, N.M. Kapranov, K.A. Nikiforova, E.N. Parovichnikova
    503-512
    01.10.2021
  • Molecular Profiling and Minimal Residual Disease Monitoring in Multiple Myeloma Patients: A Literature Review

    Aleksandra Vladimirovna Semyanikhina, E.E. Tolstykh
    436-443
    01.10.2021
  • Mastocytosis in Adults: A Retrospective Analysis of the Clinical Course and Treatment of 58 Patients

    Vsevolod Gennadevich Potapenko, V.V. Baikov, I.E. Belousova, E.A. Belyakova, M.V. Barabanshchikova, D.V. Zaslavsky, I.S. Zyuzgin, A.V. Klimovich, Yu.A. Krivolapov, T.G. Kulibaba, E.V. Lisukova, E.E. Leenman, L.A. Mazurok, A.M. Maksimova, E.V. Morozova, A.S. Nizamutdinova, K.A. Skoryukova, E.A. Ukrainchenko, N.V. Medvedeva
    158-166
    01.04.2021
  • Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical Trial

    Oleg Aleksandrovich Shukhov, A.N. Petrova, E.Yu. Chelysheva, A.V. Bykova, I.S. Nemchenko, A.G. Turkina
    1-12
    01.01.2021
  • Mantle Cell Lymphoma: History, Current Principles of Diagnosis, and Treatment (Literature Review)

    Gayane Sepugovna Tumyan
    366-381
    01.10.2020
  • Comparative Analysis of Cardiovascular Disorders in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

    L.M. Makeeva, E.I. Emelina, A.V. Bykova, Gennadii Efimovich Gendlin, G.A. Gusarova, I.G. Nikitin, E.Yu. Chelysheva, O.Yu. Vinogradova, I.E. Lazarev, E.G. Arshanskaya, A.G. Turkina
    104-111
    01.01.2020
  • Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation

    Mikhail Yur’evich Drokov, A.A. Dmitrova, L.A. Kuzmina, V.A. Vasil’eva, E.D. Mikhaltsova, O.M. Koroleva, E.V. Usikova, E.N. Parovichnikova, V.G. Savchenko
    89-94
    01.01.2020
  • Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma

    S.V. Samarina, A.S. Luchinin, N.V. Minaeva, I.V. Paramonov, D.A. D’yakonov, E.V. Vaneeva, V.A. Rosin, S.V. Gritsaev
    385-390
    01.10.2019
  • Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

    Elena Romanovna Shilova, T.V. Glazanova, Zh.V. Chubukina, O.E. Rozanova, M.N. Zenina, A.V. Seltser, V.I. Rugal, V.A. Balashova, V.A. Kobilyanskaya, I.I. Krobinets, V.Yu. Udal’eva, I.I. Zotova, L.V. Stelmashenko, N.A. Romanenko, T.B. Zamotina, I.V. Khorsheva, S.V. Voloshin
    319-328
    01.07.2019
  • Clinical Value of miR-3151 Overexpression in Synergistic Interaction with BAALC Host Gene in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

    Alena Igorevna Shakirova, I.M. Barkhatov, A.I. Churkina, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev
    303-308
    01.07.2019
  • Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)

    Oleg Aleksandrovich Shukhov, A.G. Turkina, E.Yu. Chelysheva, A.V. Bykova, A.N. Petrova, G.A. Gusarova, I.S. Nemchenko, A.O. Abdullaev, T.N. Obukhova, A.B. Sudarikov
    194-201
    01.04.2019
  • Rhythm and Conduction Disorders in Patients Receiving Ibrutinib

    E.I. Emelina, Gennadii Efimovich Gendlin, I.G. Nikitin, E.A. Dmitrieva, E.A. Nikitin, V.V. Ptushkin
    220-230
    01.04.2019
  • Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)

    Ekaterina Yur’evna Chelysheva, A.G. Turkina, E.S. Polushkina, M.A. Vinogradova, R.G. Shmakov
    202-210
    01.04.2019
  • Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

    Vladimir Ivanovich Vorob’ev, V.A. Zherebtsova, E.I. Dubrovin, L.A. Bychenkova, Yu.B. Kochkareva, L.A. Mukha, V.L. Ivanova, N.K. Khuazheva, V.V. Ptushkin
    165-172
    01.04.2019
  • Diagnosis of Acute Lymphoblastic Leukemia Originating From T-Lineage Precursors and Approaches to Minimal Residual Disease Monitoring

    Ol’ga Alekseevna Chernysheva, L.Yu. Grivtsova, I.N. Serebryakova, N.A. Kupryshina, E.N. Sholokhova, M.A. Shervashidze, A.D. Palladina, B.V. Kurdyukov, A.V. Popa, N.N. Tupitsyn
    79-85
    01.01.2019
1 - 40 of 71 items 1 2 > >> 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    3700
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    2034
  • Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)
    1535
  • Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
    1521
  • Overt and Masked Polycythemia Vera Within the Scope of Ph-Negative Myeloproliferative Diseases
    1221

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up